Opening Remarks
Dr. Edward Benz,
CEO of Dana-Farber Cancer Institute, Harvard
Medical
School
Technology Innovation
Xiaoliang Xie,
Professor, Harvard University, Member of National
Academy of Sciences
Life at the Single Molecule Level
Yi Zhang
, Professor, Harvard Medical School,
Investigator of
Howard Hughes Medical Institute
Understanding Active Demethylation and SCNT through Tool Development
Feng Zhang,
Assistant Professor, Massachusetts Institute of
Technology
Genome Editing Technologies and Applications
Peng Yin,
Associate Professor, Wyss Institute, Harvard Medical
School
DNA Probes for Highly Multiplexed Super-resolution Imaging
Cancer Research and Therapeutics
Lieping Chen,
Professor, Director of Cancer Immunotherapy, Yale
University
A Perspective in Immune Modulation Therapy of Cancer
Jean Zhao
, Associate Professor, Dana-Farber Cancer Institute,
Harvard
Medical School
Targeting the PI3K/PTEN Pathway in Cancer: from Mouse Genetics to Human
Therapies
Translational Medicine
David Williams,
Professor, Director of Clinical and Translational
Research, Boston Children’s Hospital, Harvard Medical School
Update on Use of Gene Therapy for Monogenic Diseases: the Bad, the Good and
the Future
Dr. Guangping Gao,
Professor, University of Massachusetts Medical
School
Viral Vector-Based In Vivo Gene Therapy
为神马没有小薇?